AGNPF

ALGERNON PHRMCTCLS A INC by Algernon Pharmaceuticals Inc. (AGNPF)

About ALGERNON PHRMCTCLS A INC by Algernon Pharmaceuticals Inc. (AGNPF)

Algernon Pharmaceuticals, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.12
52 Week Low
$0.04
Market cap
1.4M
Dividend yield
0.00%
Volume
30
Avg. volume
1,755
P/E ratio
-4.48

ALGERNON PHRMCTCLS A INC by Algernon Pharmaceuticals Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.12
52 Week Low
$0.04
Market cap
1.4M
Dividend yield
0.00%
Volume
30
Avg. volume
1,755
P/E ratio
-4.48